Medicines Development for Global Health develops medicines and vaccines for neglected diseases. Our approach is to bring together the ideas of researchers with our development expertise and passion to develop new products that will be life changing for millions. We are a non-profit company - all funds in excess of expenses are devoted to this purpose. In June 2018 we received FDA approval of moxidectin, the first new treatment for River Blindness in more than 30 years. Next we're turning our attention to seeing the benefit moxidectin might bring to other neglected tropical diseases and scabies. Read more at medicinesdevelopment.com. Games to be changed. Much work to do. Sign up for our quarterly newsletter here: https://bit.ly/3mwzi0N
